[Congressional Record Volume 165, Number 198 (Wednesday, December 11, 2019)]
[Senate]
[Pages S6972-S6973]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]
Nomination of Stephen Hahn
Mr. DURBIN. Mr. President, I am going to take a chance this afternoon
and vote for one of the President's nominees. Some of my colleagues
have come up to me and said I am making a big mistake, and I hope I am
not.
His name is Stephen Hahn. He is a medical doctor and an oncologist
from MD Anderson in Texas, and he has been named to serve as the Food
and Drug Administration Commissioner.
This is a relatively small agency by Federal standards that has a
major-size impact on the lives of Americans and beyond. I think it is
one of our most important agencies. It regulates so many things
relating to safety and quality of life, and Dr. Hahn would come to this
position at an auspicious moment in our history.
I refer, of course, to the fact that we are now battling a vaping
epidemic across the United States of America.
The Presiding Officer, from Utah, and I have worked on this together,
and I thank him for his leadership in this regard.
I look at Dr. Hahn and I think of all the questions that I have asked
him. I had a face-to-face meeting with him in my office and then had
him on the phone last night for another half hour, and he was very
patient in answering my questions.
[[Page S6973]]
I asked him about the vaping crisis we face, the epidemic that we
face. He readily concedes that this is something he feels very strongly
about.
The latest disclosure from the youth tobacco report suggests that 28
percent or more of high school students across the United States are
currently using e-cigarettes or vaping. Yesterday, I had a group of
high school students from New York who asked to see me, and they said:
Senator, you are wrong. It is over half.
A majority of the students in high school now are using JUUL devices,
or vaping devices, and these flavors, and they have developed nicotine
addictions, which have become controlling in their lives and it affects
the way they feel and the way they perform as students.
That is why it is so important, from my point of view, for Dr. Hahn
to make this a major priority. He assured me that he would. He reminded
me that he is a lung cancer doctor, and we had a long conversation
about my father, who died of that disease, and tobacco and the impact
it had on his life. I felt sincerity on the part of the doctor when he
was discussing this.
We talked about working with Dr. Azar, who has been an ally in this
conversation about controlling vaping devices and cigarettes.
He said that regardless of how I voted for him, he would look forward
to working with me. I am going to vote for him as the new FDA
Commissioner. It is a leap of faith because I am not certain where the
President of the United States is at this moment.
The Presiding Officer was at a meeting a couple of weeks ago in the
White House, and I have commended him for the questions he asked there,
hoping to hold the President and First Lady to their promise of
September 15 to really take on this epidemic of vaping and e-
cigarettes. I don't know at this moment whether he is going to continue
in that effort or whether the vaping industry has diverted him to a
different point of view.
Dr. Hahn may find himself in a compromised position soon, and I told
him as much. If it comes to the point where the President has abandoned
his effort against vaping and the industry is going to prevail, then, I
am afraid that Dr. Hahn is going to be wearing the collar for some of
the things that follow. Even though he may not even agree with the
President's conclusion, he will be working for the President as part of
his administration.
Dr. Hahn said to me: I don't want to be known in history as the head
of the FDA who saw this epidemic grow dramatically when it comes to
vaping by young people.
I am going to give him my vote, and I do it with the hope that he
will have a persuasive voice with Dr. Azar and the administration to
move in the right direction.
I applauded President Trump--which is unusual from my side of the
aisle--when he made his initial decision to take action against e-
cigarettes, and I would like to applaud him again. I hope he will
resume this effort. I hope the First Lady, who rarely gets engaged in
issues but seems to feel very strongly about this, will join us in
persuading the President to keep true to his promise of September 15.
I will be supporting Dr. Hahn's nomination for FDA Commissioner.